Search Results

There are 8405 results for: content related to: Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy

  1. Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 636–638, Tom T. Karnezis and Terence M. Davidson

    Article first published online : 16 DEC 2010, DOI: 10.1002/lary.21415

  2. Safety of intranasal Bevacizumab (avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis

    The Laryngoscope

    Volume 121, Issue 3, March 2011, Pages: 644–646, Sonia Chen IV, Tom Karnezis and Terence M. Davidson

    Article first published online : 11 NOV 2010, DOI: 10.1002/lary.21345

  3. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial

    Head & Neck

    Dominik Riss, Martin Burian, Axel Wolf, Veronika Kranebitter, Alexandra Kaider and Christoph Arnoldner

    Article first published online : 30 APR 2014, DOI: 10.1002/hed.23655

  4. The effect of bevacizumab (Avastin) treatment on epistaxis in hereditary hemorrhagic telangiectasia

    The Laryngoscope

    Volume 119, Issue 5, May 2009, Pages: 988–992, Jana Simonds, Frank Miller, Jess Mandel and Terence M. Davidson

    Article first published online : 4 FEB 2009, DOI: 10.1002/lary.20159

  5. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: Effectiveness of an injection protocol based on the vascular anatomy of the nose

    The Laryngoscope

    Volume 122, Issue 6, June 2012, Pages: 1210–1214, Sinan Dheyauldeen, Amy Østertun Geirdal, Terje Osnes, Liv Sofie Vartdal and Ralph Dollner

    Article first published online : 7 MAY 2012, DOI: 10.1002/lary.23303

  6. You have free access to this content
    Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas

    Cancer

    Volume 116, Issue 17, 1 September 2010, Pages: 3988–3999, Marc C. Chamberlain

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25256

  7. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases

    British Journal of Surgery

    Volume 98, Issue 3, March 2011, Pages: 399–407, D. A. Wicherts, R. J. de Haas, M. Sebagh, E. Saenz Corrales, D. L. Gorden, F. Lévi, B. Paule, D. Azoulay, D. Castaing and R. Adam

    Article first published online : 15 DEC 2010, DOI: 10.1002/bjs.7368

  8. Retina, Vitreous

    Clinical & Experimental Ophthalmology

    Volume 36, Issue s1, June 2008, Pages: A459–A584,

    Article first published online : 18 JUL 2008, DOI: 10.1111/j.1442-9071.2008.01760.x

  9. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik and Barbara S Hawkins

    Published Online : 29 AUG 2014, DOI: 10.1002/14651858.CD005139.pub3

  10. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting and Susanne Unverzagt

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD008941.pub2

  11. Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with rendu-osler disease

    The Laryngoscope

    Volume 122, Issue 5, May 2012, Pages: 953–955, Romain Guldmann, Agnes Dupret, Yasmine Nivoix, Philippe Schultz and Christian Debry

    Article first published online : 23 MAR 2012, DOI: 10.1002/lary.23230

  12. Anti-angiogenic therapies for metastatic colorectal cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea ADW Wagner, Dirk Arnold, Axel AG Grothey, Johannes Haerting and Susanne Unverzagt

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD005392.pub3

  13. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 726–734, Axel Grothey, E. Dawn Flick, Allen L. Cohn, Tanios S. Bekaii-Saab, Johanna C. Bendell, Mark Kozloff, Nancy Roach, Yong Mun, Susan Fish and Herbert I. Hurwitz

    Article first published online : 16 MAY 2014, DOI: 10.1002/pds.3633

  14. Bevacizumab (Avastin)

    Handbook of Therapeutic Antibodies

    Eduardo Díaz-Rubio, Edith A. Perez, Guiseppe Giaccone, Pages: 779–812, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch29

  15. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, Vittorio Bertele, Annalisa Campomori, Usha Chakravarthy, Roberto D'Amico, Kay Dickersin, Laurent Kodjikian, Kristina Lindsley, Yoon Loke, Maureen Maguire, Daniel F Martin, Alessandro Mugelli, Bernd Mühlbauer, Isabel Püntmann, Barnaby Reeves, Chris Rogers, Christine Schmucker, Manju L Subramanian and Gianni Virgili

    Published Online : 15 SEP 2014, DOI: 10.1002/14651858.CD011230.pub2

  16. Angiogenesis inhibitors for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum and Jo Morrison

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD007930.pub2

  17. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model

    Journal of Evaluation in Clinical Practice

    Volume 18, Issue 2, April 2012, Pages: 247–255, Jignesh J. Patel, Margaret A.S. Mendes, Mark Bounthavong, Melissa L.D. Christopher, Daniel Boggie and Anthony P. Morreale

    Article first published online : 16 SEP 2010, DOI: 10.1111/j.1365-2753.2010.01546.x

  18. You have free access to this content
    Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: e304–e310, Yu Xu, Qi Zhang, Xiaoli Kang, Ying Zhu, Jiakai Li, Yiye Chen and Peiquan Zhao

    Article first published online : 7 MAY 2013, DOI: 10.1111/aos.12055

  19. You have free access to this content
    Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation

    Acta Ophthalmologica

    Volume 90, Issue 5, August 2012, Pages: e389–e398, Ching-Long Chen, Chang-Min Liang, Yi-Hao Chen, Ming-Cheng Tai, Da-Wen Lu and Jiann-Torng Chen

    Article first published online : 19 JUN 2012, DOI: 10.1111/j.1755-3768.2012.02426.x

  20. Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases

    Journal of Surgical Oncology

    Volume 106, Issue 7, 1 December 2012, Pages: 892–897, Anne E.M. van der Pool, Hendrick A. Marsman, Joanne Verheij, Fibo J. Ten Kate, Alexander M.M. Eggermont, Jan N.M. IJzermans and Cornelis Verhoef

    Article first published online : 2 MAY 2012, DOI: 10.1002/jso.23142